InnovAge Holding Corp.(INNV)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,683 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
INNV Stock Analysis & AI Quality Score
AI stock analysis and institutional research for InnovAge Holding Corp. (INNV), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INNV at 46.1/100 on a 32-signal composite quality model, placing it at rank #1,683 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (25.3) and institutional flow (29.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q3 2026), InnovAge Holding Corp. reports quarterly revenue of $251.9M, net income of $-29.5M, free cash flow of $14.5M. Top institutional holders of INNV by reported 13-F value include BlackRock,, Coliseum Capital Management,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. INNV trades on the Nasdaq exchange and files with the SEC under CIK 1834376. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INNV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InnovAge Holding Corp. directly from SEC EDGAR. InnovAge Holding Corp.'s 13F Pro composite quality score has ranged between 33 and 49 since 2024, currently 46.1 — an improving long-term trajectory across 15 quarterly and live scoring snapshots.
Revenue
Q3 2026
$251.9M
Net Income
Q3 2026
$-29.5M
Free Cash Flow
Q3 2026
$14.5M
D/E Ratio
Q3 2026
0.25
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+24.1% YoYNet Income
+25.5% YoYOperating Income
+39.7% YoYEPS (Diluted)
+26.7% YoYTotal Assets
-7.1% YoYTotal Debt
-15.4% YoYOp. Cash Flow
+62.4% YoY| Metric | FY 2025 | FY 2023 | FY 2022 |
|---|---|---|---|
| Revenue | $853.7M +24.1% | $688.1M -1.5% | $698.6M |
| Net Income | $-30.3M +25.5% | $-40.7M -523.7% | $-6.5M |
| Operating Income | $-29.8M +39.7% | $-49.4M -1021.1% | $-4.4M |
| EPS (Diluted) | $-0.22 +26.7% | $-0.30 -500.0% | $-0.05 |
| Total Assets | $526.9M -7.1% | $567.4M +2.1% | $555.6M |
| Total Debt | $62.3M -15.4% | $73.6M -4.9% | $77.4M |
| Operating Cash Flow | $32.9M +62.4% | $20.2M -25.9% | $27.3M |
Get alerted when INNV's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for InnovAge Holding Corp. including:
Top Institutional Holders of INNV
BlackRock, Inc.
$10.0M1,248,091 shColiseum Capital Management, LLC
$8.9M1,114,809 shVANGUARD CAPITAL MANAGEMENT LLC
$7.0M877,136 shGEODE CAPITAL MANAGEMENT, LLC
$4.6M573,417 shHillsdale Investment Management Inc.
$4.3M529,984 shSTATE STREET CORP
$3.5M431,426 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$3.3M417,538 shRENAISSANCE TECHNOLOGIES LLC
$3.0M370,817 shO'SHAUGHNESSY ASSET MANAGEMENT, LLC
$2.2M272,540 shNORTHERN TRUST CORP
$2.1M267,137 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $10.0M | 1,248,091 |
| Coliseum Capital Management, LLC | $8.9M | 1,114,809 |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.0M | 877,136 |
| GEODE CAPITAL MANAGEMENT, LLC | $4.6M | 573,417 |
| Hillsdale Investment Management Inc. | $4.3M | 529,984 |
| STATE STREET CORP | $3.5M | 431,426 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $3.3M | 417,538 |
| RENAISSANCE TECHNOLOGIES LLC | $3.0M | 370,817 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $2.2M | 272,540 |
| NORTHERN TRUST CORP | $2.1M | 267,137 |
More Healthcare Companies
View all Healthcare →Put INNV on your watchlist
Track score changes the day InnovAge Holding Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is INNV a good stock to buy?
13F Pro's AI-powered analysis of InnovAge Holding Corp. (INNV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for INNV are available on the INNV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own INNV?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling INNV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of InnovAge Holding Corp.'s investment landscape.